Every Form 4 that IBEX Limited (IBEX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IBEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IBEX filings page.
IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal reported the disposition of 702 Common Shares on October 7, 2026, transferring them to a third party under a legal agreement related to a divorce dated December 29, 2025. The transfer was not discretionary. His directly held position after the transfer was 41,277 Common Shares. The reported $43.16 per-share figure was the issuer's closing price on October 7, 2026.
IBEX Ltd Chief Technology Officer Michael Ringman acquired 9,038 common shares on September 30, 2026, when performance-based stock units were earned and converted into common shares. The issuer withheld 2,599 shares to satisfy tax liability upon vesting; the withholding was non-discretionary, and Ringman sold no shares for that purpose. The $43.26 figure was the common shares’ closing price on that date.
IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal acquired 2,348 performance-based stock units on September 30, 2026, upon certification of performance goals for the two-year period ending June 30, 2026; the units converted to common shares. The issuer withheld 843 shares upon vesting to satisfy his tax liability. This was described as non-discretionary, and the reported $43.26 per-share amount was the common shares’ closing price that day.
IBEX Ltd Chief Operating Officer David Martin Afdahl acquired 3,228 common shares when performance-based stock units were earned and converted on September 30, 2026. The issuer withheld 1,590 shares to satisfy his tax liability upon vesting; the withholding was not discretionary, and Afdahl did not sell shares to satisfy the liability. The stated closing price was $43.26 per common share.
IBEX Ltd Chief Sales/Marketing Officer Julie K. Casteel earned 3,228 performance-based stock units (PSUs) on September 30, 2026; the units converted to common shares. On the same date, the issuer withheld 1,271 shares to satisfy her tax liability upon vesting. The footnote says the withholding was not discretionary and that Casteel did not sell shares to satisfy the liability.
At IBEX Ltd, Chief Sales and CS Officer Bruce Neil Dawson earned and acquired 3,228 performance-based stock units on September 30, 2026, after certification of performance goals for the two-year period ending June 30, 2026; the units converted to Common shares. The issuer withheld 1,413 shares upon vesting to satisfy Dawson's tax liability. The Common shares' closing price that day was $43.26. The withholding was not discretionary, and Dawson did not sell shares to satisfy the tax liability. No Rule 10b5-1 plan is reported.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant earned and acquired 14,524 performance-based stock units (PSUs) on September 30, 2026, after certification of performance goals for the two-year period ending June 30, 2026; the PSUs converted to common shares. On the same date, IBEX withheld 6,587 shares upon vesting to satisfy Dechant’s tax liability. The withholding was not discretionary, and Dechant did not sell shares to satisfy the liability. The reported $43.26 per-share figure was the closing price that day.
IBEX Ltd Chief Legal Officer Christina Alice Trofimuk-O’Connor earned 3,228 performance-based stock units on September 30, 2026; the units converted to Common shares after certification of performance goals for the two-year period ending June 30, 2026. The issuer withheld 1,159 shares to satisfy her tax liability upon vesting. The footnote says the withholding was not discretionary and she did not sell shares to satisfy the liability; no Rule 10b5-1 plan is reported.
IBEX Ltd Chief People Officer Paul Joseph Inson acquired 2,348 common shares on September 30, 2026, when earned performance-based stock units converted to common shares. The units were earned upon certification of performance goals for the two-year period ending June 30, 2026.
The issuer withheld 1,028 common shares to satisfy Inson’s tax liability upon vesting. The withholding was not discretionary, and no shares were sold to satisfy the liability. The reported $43.26 per-share price was the issuer’s closing price on September 30, 2026.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald earned 4,196 performance-based stock units (PSUs) on September 30, 2026, after certification of performance goals for the two-year period ending June 30, 2026; the PSUs converted to Common shares. IBEX Ltd withheld 1,843 shares for Greenwald’s tax liability upon vesting; the footnote says this was not discretionary and no shares were sold by the reporting person. The reported $43.26 per share was the closing price of IBEX Ltd Common shares on September 30, 2026.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant sold 5,000 common shares on September 25, 2026, at a weighted average price of $45.0191 per share. The sales were made under his 10b5-1 Plan dated November 18, 2025, and execution prices ranged from $45.00 to $45.060. After the sale, Dechant directly held 257,011 shares.
IBEX Ltd Chief AI & Digital Officer Darwal Michael Joseph had 270 common shares withheld by the issuer on September 15, 2026, to satisfy tax liability upon vesting of RSUs. The reported per-share price was the issuer’s closing price that day: $40.28. The withholding was not discretionary, and Joseph sold no shares; his direct holdings after the transaction were 40,474 shares. No Rule 10b5-1 plan is reported.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald had 3,293 common shares withheld for tax purposes upon vesting of a restricted stock grant on September 18, 2026. The reported price was the $40.20 closing price. Direct holdings following the transaction were 60,435 common shares; no Rule 10b5-1 plan is reported.
IBEX Ltd (IBEX) director Daniella Ballou-Aares reported selling 1,500 Common Shares on September 15, 2026 in an open-market or private transaction at a price of $40.291 per share. After this transaction, she directly holds 10,395 Common Shares of IBEX. No Rule 10b5-1 trading plan is reported for this sale.
IBEX Ltd (IBEX) reported that Chief Sales/Marketing Officer Julie K. Casteel sold 17,474 Common Shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $40.41 per share. After this sale, she directly holds 100,814 Common Shares. No Rule 10b5-1 trading plan is reported for this transaction.
IBEX Ltd (IBEX) reported that its Chief Legal Officer, Christina Alice Trofimuk-O'Connor, sold a total of 9,876 Common Shares in open-market or private transactions over two days. On September 15, 2026, she sold 7,500 shares at a weighted average price of $40.3002 per share, executed in multiple trades at prices ranging from $40.25 to $40.41.
On September 16, 2026, she sold an additional 2,376 shares at a weighted average price of $39.3419 per share, in multiple trades at prices ranging from $39.34 to $39.43. No Rule 10b5-1 trading plan is reported, and post-transaction share holdings are not stated in this filing.
IBEX Ltd (IBEX) reports that Chief Executive Officer and director Robert Thomas Dechant sold 25,000 Common Shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $39.9867 per share, and now directly holds 262,011 Common Shares. No Rule 10b5-1 trading plan is reported.
IBEX Ltd (IBEX) director Zhuang Mingzhe reported selling 5,522 common shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $40.10 per share, with individual trade prices ranging from $39.82 to $40.39. After this sale, Zhuang held 2,813 common shares directly. No Rule 10b5-1 trading plan is reported for this transaction.
IBEX Ltd (IBEX) reported that Chief People Officer Paul Joseph Inson sold 2,500 Common Shares on September 16, 2026 in an open-market or private transaction at a weighted average price of $40.0658 per share, with individual trade prices ranging from $40.04 to $40.09. Following this sale, he directly holds 27,224 Common Shares.
IBEX Ltd (IBEX) disclosed that Chief Operating Officer David Martin Afdahl sold 10,819 common shares on September 14, 2026 at a weighted average price of $40.07 per share, in transactions reported as made under a Rule 10b5-1 plan dated June 8, 2026. Following these sales, he directly holds 129,187 common shares of IBEX.
IBEX Ltd (IBEX) reported that Chief People Officer Paul Joseph Inson sold 2,274 Common Shares on September 14, 2026 at $40.00 per share in an open-market or private transaction. The sale was made pursuant to a Rule 10b5-1 trading plan dated December 16, 2025, and left him holding 29,724 shares directly.
IBEX Ltd (IBEX) reported that its Chief Operating Officer, David Martin Afdahl, sold common shares in an open-market transaction. On September 8, 2026, he sold 17,500 common shares at a weighted average price of $37.0862 per share, pursuant to a Rule 10b5-1 trading plan dated June 8, 2026. Following this sale, he directly owns 140,006 common shares of IBEX Ltd.
IBEX Ltd director Fiona Elizabeth Beck acquired 1,252 Common Shares on July 31, 2026 through performance-based stock units earned upon certification of performance goals for the period ending June 30, 2026. Following this award, she directly holds 14,835 Common Shares.
IBEX Ltd director Zhuang Mingzhe acquired 1,252 Common Shares on July 31, 2026 through the earning and conversion of performance-based stock units. These PSUs were earned when performance goals for the period ending June 30, 2026 were certified. After this equity award, Zhuang directly holds 8,335 Common Shares, reflecting compensation rather than an open-market purchase or sale.
IBEX Ltd director John William Jones acquired 1,353 Common Shares on July 31, 2026 at no cost, when previously granted performance-based stock units were earned upon certification of performance goals for the period ending June 30, 2026. After this conversion, he directly holds 16,597 Common Shares.
IBEX Ltd executive Bruce Neil Dawson, Chief Sales and CS Officer, earned and acquired 1,954 performance-based stock units that converted into Common shares on July 31, 2026 after performance for the period ending June 30, 2026 was certified. To satisfy related taxes, 855 shares were withheld by the company at $35.34 per share; no shares were sold by him to cover this tax liability.
IBEX Ltd reports that Chief Financial Officer Greenwald Taylor C acquired 3,307 Common Shares on July 31, 2026 when performance-based stock units were earned for the period ending June 30, 2026 and converted to stock. On the same date, 956 shares were withheld to satisfy tax liability at 35.3400 per share; no shares were sold into the market.
IBEX Ltd reports that Chief People Officer Paul Joseph Inson earned and acquired 2,405 Common Shares on July 31, 2026, when performance-based stock units were certified for the period ending June 30, 2026 and converted to shares. To cover related taxes, the issuer withheld 1,053 shares valued at $35.34 per share; no shares were sold into the market.
IBEX Ltd director Karen Batungbacal reported an equity compensation award. On July 31, 2026, 1,252 performance-based stock units (PSUs) were earned upon certification of performance goals for the period ending June 30, 2026 and converted into Common Shares, increasing her direct holdings to 8,335 shares.
IBEX Ltd director Patrick McGinnis reported an equity award. On July 31, 2026, he acquired 1,252 Common Shares when an equal number of performance-based stock units (PSUs) were earned after certification of performance goals for the period ending June 30, 2026 and converted into shares. Following this non-market award, he holds 7,085 Common Shares directly.
IBEX Ltd director Daniella Ballou-Aares reported the acquisition of 1,252 common shares on July 31, 2026. These shares were earned as performance-based stock units after certification of performance goals for the period ending June 30, 2026 and converted to common shares. Following this award, she holds 11,895 shares directly.
IBEX Ltd reported that Chief Sales/Marketing Officer Julie K. Casteel earned and acquired 2,646 performance-based stock units on July 31, 2026, upon certification of performance goals for the period ending June 30, 2026. These units converted into common shares, and 1,042 shares were withheld to cover tax liabilities at a closing price of $35.34 per share; no shares were sold.
IBEX Ltd reported that CEO Robert Thomas Dechant acquired 10,826 common shares on July 31, 2026, when performance-based stock units earned for the period ending June 30, 2026 were certified and converted to common shares. On the same date, 4,910 shares were withheld at $35.34 per share to cover his tax liability; no shares were sold.
IBEX Ltd reported equity compensation activity for Chief Legal Officer Christina Trofimuk-O'Connor. On July 31, 2026, she earned and acquired 2,646 performance-based stock units for the period ending June 30, 2026, which converted into Common shares. To cover taxes on this vesting, 950 shares were withheld at the $35.34 closing price, and no shares were sold on the open market.
IBEX Ltd reported that Chief Operating Officer David Martin Afdahl earned and acquired 2,646 performance-based stock units on July 31, 2026, upon certification of performance goals for the period ending June 30, 2026, which converted into Common Shares. On the same date, 1,304 shares were withheld to cover tax obligations at $35.34 per share.
Darwal Michael Joseph reported disposition transactions in this Form 4 filing.
IBEX Ltd reports that Chief AI & Digital Officer Michael Joseph Darwal transferred 200 Common Shares of IBEX on 2026-07-20 at $35.07 per share. A footnote states the shares were moved to a third party under a divorce-related legal agreement and do not represent a discretionary transaction. Darwal now directly holds 40,744 Common Shares.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald reported a tax-related share withholding. On July 1, 2026, 853 common shares were withheld at $31.60 per share to cover tax liability tied to the vesting of 2,948 restricted stock units. The filing states no shares were sold in the market to satisfy this tax obligation, and Greenwald now holds 61,377 common shares directly.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported a routine tax-withholding transaction related to equity compensation. On July 1, 2026, 4,511 Common Shares were withheld at $31.60 per share to cover taxes on the vesting of 9,946 restricted stock units. No shares were sold in the market, and Dechant's direct holdings after this withholding totaled 281,095 Common Shares.
IBEX Ltd Chief People Officer Paul Joseph Inson reported a tax-related share disposition. On July 1, 2026, 823 common shares were withheld by IBEX at $31.60 per share to cover tax owed when 1,880 restricted stock units vested. This withholding was done by the issuer as a net share settlement, and no shares were sold on the market to satisfy the tax liability. Following this transaction, Inson directly held 30,646 common shares, indicating the event was a routine compensation-related tax withholding rather than an open-market sale.
IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal reported a tax-related share withholding tied to restricted stock unit vesting. On July 1, 2026, 316 common shares were withheld at $31.60 per share to cover tax obligations when 880 restricted stock units vested. The filing notes that no shares were sold on the market to satisfy this tax liability, and Darwal now directly holds 40,944 common shares following the transaction.
IBEX Ltd Chief Sales/Marketing Officer Julie K. Casteel reported a routine tax-withholding share disposition linked to RSU vesting. On July 1, 2026, 910 common shares were withheld at $31.60 per share to cover taxes on 2,310 vested restricted stock units. The footnote states no shares were sold by Casteel to satisfy this tax liability. After the withholding, she directly holds 116,684 common shares.
IBEX Ltd Chief Operating Officer David Martin Afdahl reported a routine tax-related share disposition. On July 1, 2026, 1,138 common shares were withheld by IBEX to cover his tax liability from the vesting of 2,310 restricted stock units. The footnote clarifies that no shares were sold on the market to satisfy this obligation. After this withholding, Afdahl directly owned 156,164 IBEX common shares.
IBEX Ltd Chief Legal Officer Christina Alice Trofimuk-O'Connor reported a tax-related share disposition. On July 1, 2026, 700 common shares were withheld by IBEX at $31.60 per share to cover taxes on the vesting of 2,310 restricted stock units. According to the filing, no shares were sold to the market, and she now directly holds 35,035 common shares.
IBEX Ltd reported a routine insider transaction involving Chief Sales and CS Officer Bruce Neil Dawson. On July 1, 2026, 886 common shares were withheld by the company at $31.60 per share to cover tax obligations arising from the vesting of 2,022 restricted stock units. The footnote clarifies that no shares were sold in the market to satisfy this tax liability. After this tax-withholding disposition, Dawson directly holds 61,009 common shares.
IBEX Ltd reported an insider transaction by Chief Sales/Marketing Officer Julie K. Casteel. On June 11, 2026, she completed an open-market sale of 3,600 Common Shares at a weighted average price of $30.6065 per share. After this sale, she directly holds 117,594 Common Shares. The sale was executed in multiple trades, with individual prices ranging from $30.465 to $30.78, and the weighted average price aggregates those trades.
IBEX Ltd director Patrick McGinnis sold shares in a routine insider transaction. On May 28, 2026, he completed an open-market sale of 1,030 Common Shares at $31.69 per share. After this sale, he continues to hold 5,833 Common Shares directly.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald reported two share transactions in Common Shares. On May 22, 2026, he sold 964 shares in an open-market sale at $32.02 per share and acquired 3,333 shares from earned performance-based stock units. After these transactions, he directly owned 62,230 Common Shares.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant sold 7,800 common shares in an open-market transaction. The shares were sold at a weighted average price of $30.4996 per share, with individual trades executed between $30.37 and $30.88. After this sale, Dechant directly holds 285,606 IBEX common shares.
IBEX Ltd Chief Sales and CS Officer Bruce Neil Dawson reported two open-market sales of Common Shares. On May 11, 2026, he sold 3,129 shares at a weighted average price of $32.8038 per share. On May 12, 2026, he sold 15,260 shares at a weighted average price of $31.1156. After these transactions, he directly owns 61,895 Common Shares.
IBEX Ltd director Daniella Ballou-Aares reported selling 6,500 Common Shares in open-market transactions and now holds 10,643 shares directly. The sales included 5,843 shares at $24.2175 and 157 shares at $24.2114 on March 13, 2025, plus 500 shares at $35.01 on December 2, 2025.